Nigeria has reported eight new confirmed cases of Mpox with the disease spreading across 35 Local Government Areas (LGAs) in 20 states and the Federal Capital Territory (FCT).
Records indicate a sharp increase in week 34, with eight confirmed cases reported, compared to just one case in week 33, 2024.
According to the Nigeria Centre for Disease Control (NCDC),at least 19 states, including the FCT, have each recorded one confirmed case of Mpox since the outbreak began earlier this year.
This brings the total to 48 confirmed Mpox cases out of 868 suspected cases, a rise from the previous week’s report of 40 confirmed cases out of 830 suspected cases.
The country has not yet recorded any deaths from the outbreak according to the Mpox situation report published on the agency’s website on Friday.
NCDC records showed that Lagos had (one), Rivers (two), Bayelsa (six), Abia (one), Delta (two), Imo (one), Edo (one), FCT (two), Anambra (two), Cross River (five).
Others are Plateau (two), Akwa Ibom (four), Nasarawa (one), Oyo (one), Kaduna (one), Ebonyi (one), Benue (three), Enugu (eight), Osun (two), Kebbi (one), and Zamfara (one).
The report clarified that “57 new suspected cases were reported in Epi week 34, 2024, compared with 25 cases reported in the previous week (Epi week 33).
“Eight confirmed cases were reported in week 34 compared with one (1) confirmed case reported in week 33, 2024.
“Twenty states and the FCT have recorded at least one confirmed case across thirty-five (35) Local Government Areas in 2024”.
According to the agency, the age distribution of the cumulative number of confirmed cases showed that 17 cases were recorded among ages 0-10; seven cases were recorded among ages 11-20; nine cases were recorded among 21-30; eight cases were recorded among ages 31-40; and seven cases were recorded among ages 41-50.
However, during the week, Nigeria received 10,000 doses of the Jynneos vaccine as a donation from the United States government as part of efforts to combat the disease outbreak in the country.
The vaccine, which is approved by the United States Food and Drug Administration (FDA) for the prevention of smallpox and Mpox in adults at risk, was officially handed over to the Nigerian government at a ceremony held in Abuja on Tuesday.
During the same period, the Africa Centres for Disease Control and Prevention (Africa CDC) also reinforced its declaration of Mpox a Public Health Emergency of Continental Security (PHECS) after a 160% increase in cases this year.
